People

You are here

Hooman's photo
Hooman Kamel, M.D., M.S.
GUEST SPEAKER

Hooman Kamel, M.D., M.S.

Associate Professor of Neurology
Vice Chair for Research and Chief of Neurocritical Care
Department of Neurology
Director, Clinical and Translational Neuroscience Unit
Feil Family Brain and Mind Research Institute
Weill Cornell Medicine

Dr. Hooman Kamel is the Vice Chair for Research and Chief of Neurocritical Care in the Department of Neurology at Weill Cornell Medicine. He is also the Director of the Clinical and Translational Neuroscience Unit in the Feil Family Brain and Mind Research Institute and the Department of Neurology at Weill Cornell Medicine. His research focuses on the relationship between cardiac disease and stroke. He has published several studies showing that atrial cardiopathy may be a previously unrecognized risk factor for stroke. He is a principal investigator for the NIH-funded trials: ARCADIA, which is testing antithrombotic strategies in patients with stroke and atrial cardiopathy, also ASPIRE, which is testing antithrombotic strategies in patients with atrial fibrillation and intracerebral hemorrhage. He has published over 300 scientific publications. Dr. Kamel attended college at Harvard and medical school at Columbia, then trained as a neurology resident and neurocritical care Fellow at the University of California, San Francisco before joining Weill Cornell Medicine in 2011. He has a Masters Degree in data science from the Columbia University Data Science Institute and is spearheading efforts to establish neurocritical care research registries using existing electronic medical records. Dr. Kamel has led multiple studies using novel “big data” approaches on a variety of topics including cardiovascular complications of pregnancy, liver disease, and sepsis. Dr. Kamel is a member of the international AF-SCREEN collaboration and the American Neurological Association Scientific Program Advisory Committee. He serves as the Deputy Editor of JAMA Neurology and an editorial board member of Stroke. His academic contributions have been recognized by the Michael S. Pessin Stroke Leadership Prize from the American Academy of Neurology, the Robert G. Siekert New Investigator Award in Stroke, and the Joseph A. Vita Award from the American Heart Association.